Pharmacokinetics of Maribavir, a Novel Oral Anticytomegalovirus Agent, in Subjects With Varying Degrees of Renal Impairment
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference13 articles.
1. Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease;Chulay;Adv Exper Med Biol,1999
2. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses;Williams;Antimicrob Agents Chemother,2003
3. Potent and selective inhibition of human cytomegalovirus replication by 1263W94: a benzimidazole L-riboside with a unique mode of action;Biron;Antimicrob Agents Chemother,2002
4. Inhibition of ganciclovir-susceptible and resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94;McSharry;Clin Diagn Lab Immunol,2001
5. Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects;Wang;Antimicrob Agents Chemother,2003
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of the drug maribavir according to clinical studies;Clinical Medicine (Russian Journal);2024-05-07
2. Effect of Food, Crushing of Tablets, and Antacid Coadministration on Maribavir Pharmacokinetics in Healthy Adult Participants: Results From 2 Phase 1, Open‐Label, Randomized, Crossover Studies;Clinical Pharmacology in Drug Development;2024-05-06
3. Antiviral Agents: Maribavir;Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century;2024
4. Anti-CMV therapy, what next? A systematic review;Frontiers in Microbiology;2023-11-20
5. Pharmacokinetics and Safety Evaluation of Maribavir in Healthy Japanese and Matched White Participants: A Phase 1, Open‐Label Study;Clinical Pharmacology in Drug Development;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3